If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Traced the original agreement with CII back to December 2017. That's a long time with not much to show for.
Oops should be PBX board
apologies
mol
No not us per se but seed in at no 4 according to Success magazine
Most Innovative Company in Health & Wellness
4. Seed Health Inc.
Who they are: Seed is a direct-to-consumer, research-backed probiotic company whose products are available for a monthly subscription fee of $49.99.
How they innovate: The company believes “the science of probiotics demands a new standard.” Currently, the company offers just two consumer products; however, the science and testing that go into their products is anything but limited. Based on robust clinical research, it collects probiotic strains and puts them to the test in a high-tech simulator known as SHIME®, which mimics biological conditions from stomach to colon. Formula information and testing data are transparent and accessible, and its scientific board includes researchers from the National Institutes of Health’s Human Microbiome Project.
Financials: Seed is a privately held company; revenue and earnings are not publicly available. According to WWD, the company raised $40 million in Series A funding in 2021.
Impact: Seed’s combination of scientific rigor, social impact work and award-winning product design, plus a subscription model that eliminates the overhead of brick-and-mortar retail, make it a standout in an otherwise overcrowded and underregulated supplements industry.
https://www.success.com/most-innovative-companies-2024/
mol
Remember them - well they are attending Natural Products Expo West 12-16 March in Anaheim CA (not their first time i think)
CII manufactures colored and flavored particulates that can be Natural, Non-GMO, Organic, Gluten Free and truly be manufactured to meet our customers needs. CII manufactures direct expanded whole grain, protein and microbiome crisps. CII also manufactures customer granolas, clusters and panned items at our new facility in St. Joseph, MO. CII has partnered with Optibioitix to represent their interest in North America to showcase Slimbiome, a weight management microbiome. Stop by our booth #122 in the Arena and evaluate our new Plant-Based protein samples that can be utilized in numerous applications.
https://expowest24.smallworldlabs.com/cii
mol
Re the auditors. SOH has expressed frustration with Auditors, I seem to remember.
Good start to 2024 regarding breakfast smoothie though
14 - 5 star, 1 - 4 star and a 3 star
with the undernoted today
Delicious!
Overall: 5
Mixability: 5
Taste: 5
Effectiveness: 5
Really tasty and not grainy like other shakes I’ve had. Perfect to get protein in the morning and I just wish I bought a bigger bag!
20/02/2024 by Maddie
Verified Purchase
https://www.myprotein.com/sports-nutrition/breakfast-smoothie/13251950.reviews
mol
In terms of the SP drop - though it was announced 11 days ago, news of Opti's auditor swap may have shaken confidence.
It's not 100% clear to me whether this was Opti's decision or the auditor's, though the phrase "its termination as auditor" suggests the former.
The RNS does state the old auditor "is not aware of any circumstances connected with its termination as auditor that it considers should be brought to the attention of the Board, creditors or shareholders of the Company."
Even so, there's always a reason (though it could be something as innocent as cost / culture clash / perceived incompetence of former auditor).
There was a trading update on 28th Feb 22, but nothing around that date last year.
So as martinu rightly said, they're ad hoc.
Trading update are always given end of February each year so I suppose 2023 is another year not pretty
Results are usually published in June for YE Dec. We have had trading updates in the past, but these are ad hoc, so difficult to predict when they might be posted.
SlimBiome products , etc have been the main stay, since PBX was hived off. And this is a very crowded market, so don't expect massive returns there.
The long anticipated and hoped for SweetBiotix commercialisation, is still that! And whilst we have some advantage in science backed claims, competition must be growing there. And because the development partners for Sweet are, we are told, big players. We go at their pace.
Even so the SP was holding its own, with the usual sideways and slightly downward shift. So today's bigger drop is a bit disappointing. So my guess is the fall is due to lack of news/patience. The latter being understandable.
I don’t think they are selling any volume in Holland and Barrett,that’s for sure.
Are results due
Sadly the volume is high. Much higher than the daily average
Big drop today on low volume. Some kind of game going on?
Pglancy
Yes see my apology on SBTX BB I mixed up Opti and SBTX and you were talking about selling Optis hares not SBTX.It was simply a mix up between the two shares nothing more sinister than that but of course I apologise for the mistake because accuracy is an obsession of mine.
'O fcourse the troll with a grudge nick plays the support role and wonders why he is 'hated.' Its not hate, its loathing and contempt because most of your effort is aimed at killing off avenues for investor communications with the company because you think you have the monopoly on the ability to read an rns. The sheer arrogance of you nick is putrid.'
1/ I don't wonder why I am hated and I did say universally hated, somebody said it . Not sure it's true not sure it's untrue. But I am not a troll (traitor). I am a shareholder (faithful). Cue Ms Winkleman
2/ I did nothing to cut off investor communication. I asked QUESTIONS of the nomad. The nomad did what he did. What else have I done towards 'killing off investor communications',?
3/ So I am 'hated' loathed held in contempt and now arrogant as well as putrid. wow. Monopoly on the ability to read an RNS? Where does that come from?
4/ I don't think I commented on aquas content. I did tick up actually and have thanked him in the past. FDA approval is difficult though.
5/ I do value the input of mol though, and like to support him. No way is he a troll (back to traitors) and I am appalled you think so. You need to control your anger.
PGlancy
This topic has nothing to do with the aqua research. Going to apologise? Title gives a clue.
Hi PG, yes accept that the labelling is the final outcome from the regulatory review. My interpretation of the progress reported in the RNS's is that the US Partner Mogroside based products have completed scale-up, undergone independent taste and structure analysis and hence the granulated version is ready for regulatory evaluation and classification for the Country a launch is aimed at. The fact that the initial launch is as a standalone product rather than as an ingredient incorporated in someone else's end product will simplify matters. Firmenich have yet to complete the optimised scale-up of their Stevenol based sweetbiotix products which I suspect will also need to undergo independent taste and structural tastes prior to any regulatory submissions.
Or they are as stupid as you mol. Thats my take on them voting up. They have not done the research aqua has, that's what those votes mean. Good spin though. Pathetic.
You can't make it up. The trolls see lemmings everywhere. Aqua goes into great detail helping investors understand the sugar labelling process in stateside and gets attacked by super troll mol. Instead of being grateful he uses the confession from aqua he communicated questions for lemmings to bat to SOH and get answers. Funny how that works so smoothly and hated by some self ritious trolls because all they have is hate for others work, craft and work. O fcourse the troll with a grudge nick plays the support role and wonders why he is 'hated.' Its not hate, its loathing and contempt because most of your effort is aimed at killing off avenues for investor communications with the company because you think you have the monopoly on the ability to read an rns. The sheer arrogance of you nick is putrid.
Aqua, i for one am grateful for your version of the lemming article. It was a very good supplement. However, i am not convinced sweetbiotix is down to just labeling stage of commercial viability.
Come on mol you are important here. Stop doing an impression of eeyore:). At least you are not universally hated as I am (post on Sbtx).
Topic titled podcast on sbtx dated 1/4/23 may help
Https://www.optibiotix-ir.com/content/news/archive/2023/190723
Yep read it - again
Still no FDA reference
I can just imagine texts, phone conversations , whats app
Whatever
I,m really not that important here - for the second time tonight
mol
Mol, read the 19th July RNS meeting the market need section and you will see mention of both the nutrional label and sweetbiotix as dietary fibers, all I have done is research the US label classifications to conclude what lies ahead once sweetbiotix are incorporated into suppliers products in the US
Aquae
I'm really not that important here and for you to take that reaction is - for the second time tonight - even more over the top
please continue to share your thoughts and have lemming thanks/hints on this bb
mol